Christopher P. Lowe's Net Worth
$3.49 Million
Who is Christopher P. Lowe?
Christopher P. Lowe has an estimated net worth of $3.49 Million. This is based on reported shares across multiple companies, which include Inspyr Therapeutics, Inc., Vincera Pharma, Inc., Cortexyme, Inc., Anthera Pharmaceuticals Inc, and HANSEN MEDICAL INC.
SEC CIK
Christopher P. Lowe's CIK is 0001376260
Past Insider Trading and Trends
2021 was Christopher P. Lowe's most active year for acquiring shares with 10 total transactions. Christopher P. Lowe's most active month to acquire stocks was the month of May. 2021 was Christopher P. Lowe's most active year for disposing of shares, totalling 16 transactions. Christopher P. Lowe's most active month to dispose stocks was the month of July. 2021 saw Christopher P. Lowe paying a total of $692,732.55 for 206,963 shares, this is the most they've acquired in one year. In 2021 Christopher P. Lowe cashed out on 183,926 shares for a total of $3,668,707.94, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Inspyr Therapeutics, Inc. (RBSH) Snapshot price: $0.000001
President and CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Vincera Pharma, Inc. (VINC) Snapshot price: $0.7122
InvestorChristopher P. Lowe owns 40,000 units of Common Stock which is worth $28,488.00. In the year 2020 Christopher P. Lowe filed a total of 6 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +300.00% | 30K |
$1.65 | $49,438.12 | 40K |
Aug 24 - Aug 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 26
| |||
Form 4
|
∞
| 10K |
$12.62 | $126,152.00 | 10K |
Jun 29 - Jun 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Cortexyme, Inc. (QNCX) Snapshot price: $0.71
Interim CEO, COO & CFOChristopher P. Lowe owns 265,000 units of Common Stock which is worth $188,150.00. In the year 2019 Christopher P. Lowe acquired a total of 311,963 shares in Cortexyme, Inc. at a cost of $566,580.55, Christopher also disposed a total of 46,963 shares of Cortexyme, Inc. equalling to $3,668,707.94.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +194.44% | 175K |
—
|
—
| 265K |
Mar 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
| +50.00% | 30K |
$2.23 | $66,900.00 | 90K |
Nov 16
| |||
Form 4
|
—
|
0
|
$76.68 | -$216,634.95 | 60K |
Scheduled
|
Oct 5
| ||
Form 4
| +100.00% | 30K |
$48.77 | -$1,980,818.94 | 60K |
Scheduled
|
Aug 16 - Aug 17
| ||
Form 4
|
∞
| 30K |
$28.19 | -$971,573.50 | 30K |
Scheduled
|
Jun 28 - Jun 30
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Anthera Pharmaceuticals Inc No price found
CFO & VP Administration
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Dec 31
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
HANSEN MEDICAL INC No price found
Interim CFOChristopher P. Lowe used to own units in Common Stock but no longer holds any shares there. From 2006 to 2016 Christopher P. Lowe acquired a total of 142,500 shares in HANSEN MEDICAL INC at a cost of $74,490.00, Christopher also disposed a total of 104,250 shares of HANSEN MEDICAL INC equalling to $417,000.00.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -4.25K |
$4.00 | -$417,000.00 |
0
|
Jul 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 11
| |||
Form 4
| +88.89% | 20K |
$1.44 | $28,890.00 | 42.5K |
May 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 30
| |||
Form 4
| +125.00% | 12.5K |
$1.52 | $19,000.00 | 22.5K |
May 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
∞
| 10K |
$2.66 | $26,600.00 | 10K |
Apr 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||